HEMOSTASIS COAGULATION RESEARCH REAGENTS DEFICIENT PLASMAS CONGENITAL DEFICIENT PLASMAS (BOTTLES)

Human Factor XIII congenital deficient plasma (severe <1%)

Plasma from a human donor with congenital FXIII deficiency.

Packaging in bottle. The minimum packaged volume is 50 mL. The price offer is based on the volume requested.

Advantages

Minimize test time.
Ready to use.

Informations

Factor XIII is synthesized by the liver.
Activated by thrombin, FXIII intervenes in the final phase of fibrinoformation to stabilize the fibrin clot by forming covalent bonds in the fibrin polymer.

Documentation

Download the product sheet

Price list, safety data sheets and notices are accessible to our registered customers.

References

6-PPD13C-S	Vial	Minimum 50 mL

Special plasmas are derived from patients with a congenital deficiency, severe or moderate, or presenting a particular profile.
No buffer or preservatives are added. Quickly frozen at -80° C, the plasma maintains perfectly intact the matrix.
All plasmas are stable when stored at -40° C to -80° C.
We carefully pack with dry ice during shipment. No additive or preservative.
Expiry date > 1 year.
Plastic vials.

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION RESEARCH REAGENTS DEFICIENT PLASMAS CONGENITAL DEFICIENT PLASMAS (BOTTLES)

Human Factor XIII congenital deficient plasma (severe <1%)

Plasma from a human donor with congenital FXIII deficiency.

Advantages

Informations

Documentation

Price list, safety data sheets and notices are accessible to our registered customers.

References

Cryopep Catalogue
Thrombosis Haemostasis 2025

Cryopep Catalogue
Haemostasis Research 2025

Cryopep DEFICIENT PLASMAS

Product sheet Human Factor XIII congenital deficient plasma (severe <1%)

Related products: 16

Human Factor II congenital deficient plasma >5%

Human Factor IX congenital deficient plasma (severe <1%)

Human Factor IX congenital deficient plasma >5%

Human Factor V congenital deficient plasma (severe <1%)

Human Factor V congenital deficient plasma >5%

Human Factor VII congenital deficient plasma (severe <1%)

Human Factor VII congenital deficient plasma >5%

Human Factor VIII congenital deficient plasma (severe <1%)

Human Factor VIII congenital deficient plasma >5%

Human Factor X congenital deficient plasma (severe <1%)

Human Factor X congenital deficient plasma >5%

Human Factor XI congenital deficient plasma (severe <1%)

Human Factor XI congenital deficient plasma >5%

Human Factor XII congenital deficicent plasma >5%

Human Factor XII congenital deficient plasma (severe <1%)

Human Factor XIII congenital deficient plasma >5%

You must identify yourself to search for a certificate of analysis

HEMOSTASIS COAGULATION RESEARCH REAGENTS DEFICIENT PLASMAS CONGENITAL DEFICIENT PLASMAS (BOTTLES)

Human Factor XIII congenital deficient plasma (severe <1%)

Plasma from a human donor with congenital FXIII deficiency.

Advantages

Informations

Documentation

Price list, safety data sheets and notices are accessible to our registered customers.

References

Related products: 16